Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Fermented red ginseng** is a fermented **Panax ginseng** derived botanical preparation used as a dietary supplement and nutraceutical rather than a conventional pharmaceutical drug. In the provided preclinical literature, fermented red ginseng was studied orally in a high-fructose diet rat model and showed improvement in obesity-related metabolic abnormalities, including dyslipidemia, hypertension, fatty liver, endothelial dysfunction, and insulin resistance, with greater activity than non-fermented red ginseng. Its proposed mechanism is pleiotropic and not attributable to a single defined molecular target; reported effects include downregulation of endothelin-1 and vascular adhesion molecules together with upregulation of insulin receptor substrate 1 and glucose transporter type 4 in muscle, consistent with metabolic, anti-inflammatory, antioxidant, and vasoprotective activity. No specific commercial developer, manufacturer, approved drug status, or standardized pharmaceutical product identity is established from the provided evidence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fermented red ginseng.